Heard on the Street Writers Reveal Annual Stock Picks in Eighth Contest Edition
Stock Trades Linked to President Trump Prompt Scrutiny Over Potential Conflicts
Meta Could Enter Cloud Computing Business as Data Center Overcapacity Looms Zuckerberg Says
AMAs 2026 Return to Las Vegas Queen Latifah Hosts BTS Appearance Could Boost Media and Tourism
AST SpaceMobile and Rocket Lab A Comparative Analysis for 2026
Genpact CEO Suggests AI Could Reduce IT Workload and Slow Job Growth
UEC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Progress
FLNA Q3 2025 Earnings NarrowerThanExpected Loss Drives Stock Rally
Nike NKE Q1 2026 Earnings EPS Surges Past Estimates with 2289 Beat
Daxor Corporation DXR Q3 2007 Earnings Landmark EPS Beat Lifts Sentiment Despite No Revenue Disclosure
Legacy Education Inc LGCY Q1 2026 Earnings Strong EPS Beat Despite Revenue Headwinds and Stock Pullback
Almonty Industries Inc Q1 2026 Earnings EPS Misses Estimates by Wide Margin
AZZ Inc AZZ Consolidates Near Resistance After Slight Decline
aTyr Pharma ATYR Slides 27 Approaching Key Support at 048
Telomir Pharmaceuticals TELO Holds Steady at 129 as Consolidation Persists
SREA Holds Steady Near 2120 as FixedIncome Investors Eye Yield
Haverty Furniture HVT Sees Slight Decline Holds Near Support Levels
Wall Street Rallies Dow Achieves Record High Amid Optimism Over Middle East Situation
Nordson Q1 2026 Earnings Narrow EPS Miss Fails to Derail Investor Confidence
Stantec Inc STN Edges Higher With Modest Uptick as Sector Eyes Infrastructure Demand
IAG Q1 2026 Earnings EPS Surges Past Estimates Stock Reacts Negatively
CXW Q1 2026 Earnings CoreCivic Reports EPS Beat Stock Rises
ICON Q4 2025 Earnings EPS Misses Estimates Amidst Operational Challenges
Cathay General Bancorp CATY Q1 2026 Earnings Strong EPS Surprise of 2275 Drives Profit Beat Despite Stock Dip
GNLN Q2 2023 Earnings Significant Loss Per Share Misses Estimates Stock Declines
DCBO Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Gains
Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline